Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
ACXP | US
Overview
Corporate Details
- ISIN(s):
- US00510M1045
- LEI:
- Country:
- United States of America
- Address:
- 259 LIBERTY AVENUE, 10305 STATEN ISLAND
- Website:
- https://www.acurxpharma.com/
- Sector:
- Manufacturing
Description
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of antibiotics. The company's therapeutic candidates are designed to treat infections caused by bacteria designated as priority pathogens by organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). Acurx's approach involves developing antibiotics that inhibit a novel molecular target previously unexploited in medical research. A primary focus of its clinical development is the treatment of Clostridioides difficile Infection (CDI).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Acurx Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Acurx Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Acurx Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
